Patents by Inventor John Centanni

John Centanni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060258001
    Abstract: The present invention relates to in vitro cultured skin substitutes. In particular, the present invention relates to compositions and methods for the development of cultured skin substitutes using NIKS cells.
    Type: Application
    Filed: March 15, 2006
    Publication date: November 16, 2006
    Applicant: Stratatech Corporation
    Inventors: B. Allen-Hoffmann, Cathy Ivarie, John Centanni
  • Publication number: 20060222635
    Abstract: The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.
    Type: Application
    Filed: December 9, 2005
    Publication date: October 5, 2006
    Inventors: John Centanni, Lynn Allen-Hoffmann
  • Publication number: 20060051827
    Abstract: A method for increasing the sensitivity of a bio-luminescent assay comprising carrying out the assay in the presence of an organic compound that reduces luminescence that is not dependent on the presence of an analyte by at least about 10 fold, and that reduces, maintains, or increases the luminescence that is dependent on the presence of an analyte.
    Type: Application
    Filed: November 18, 2004
    Publication date: March 9, 2006
    Inventors: Erika Hawkins, John Centanni, Jacqueline Sankbeil, Keith Wood
  • Publication number: 20050079578
    Abstract: The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.
    Type: Application
    Filed: July 30, 2004
    Publication date: April 14, 2005
    Applicant: Stratatech Corporation
    Inventors: John Centanni, Lynn Allen-Hoffmann